IPO Trending
VALIANTLABEQ / NSE, BSEListed
Valiant Laboratories

Incorporated in 1980, Valiant Laboratories Limited is an Active Pharmaceutical Ingredient (API) manufacturing company in India primarily focused on producing Paracetamol. The company operates a manufacturing facility in Palghar, Maharashtra, spread across 2,000 sq. meters with a total installed annual capacity of 9,000 MT. Valiant Laboratories also has an in-house R&D facility equipped with an analytical laboratory and infrastructure to support development and improvement of existing products, strengthening its capabilities in the pharmaceutical ingredient space.

₹133 - ₹14029.75x sub
Listed Price₹162.15
Listing Gain+15.82%

Subscription Status

29.75xTotal Demand
Updated 20 Oct 2026, 01:30 AM
QIB20.83x
Hot Bidding (High Profits)Offered: 21,78,030 sh
Nib73.63x
🔥 Blockbuster Sizzling Demand!Offered: 16,33,500 sh
Hnis(10l +)78.64x
🔥 Blockbuster Sizzling Demand!Offered: 10,88,999 sh
Hnis (2-10l)63.63x
🔥 Blockbuster Sizzling Demand!Offered: 5,44,501 sh
Retail16.05x
Hot Bidding (High Profits)Offered: 38,11,500 sh
CategoryOfferedAppliedTimes
QIB21,78,0304,53,61,15520.83x
Nib16,33,50012,02,80,96573.63x
Hnis(10l +)10,88,9998,56,36,63578.64x
Hnis (2-10l)5,44,5013,46,44,33063.63x
Retail38,11,5006,11,70,90016.05x

Segment Subscription Demand

Segment / CategoryDemand (Shares)Offered (Shares)Times Sub.
QIB635.0630.4920.83x
Retail856.3953.3616.05x
Hnis 2+485.027.6263.65x
Hnis 10+1,198.9115.2578.62x
Bidding status cross-verified with live IPO subscription numbers ↗BSE & NSE Bidding Portal Feed

About Valiant Laboratories IPO Subscription Demand

Live subscription status and bidding analysis for Valiant Laboratories (VALIANTLAB) IPO. The issue is subscribed 29.75x overall across Qualified Institutional Buyers (QIB), Non-Institutional Investors (NII/HNI), and Retail Individual Investors (RII). Check real-time grey market demand on our GMP Tracker or review full issue details, lot size, and price band on the IPO Details Page.

Frequently Asked Questions